The good, the bad, and the ugly of ROS: New insights on aging and aging-related diseases from eukaryotic and prokaryotic model organisms
They reduce LDL, stabilize plaque, and cost a fraction of GLP 1s Maybe the move here is a low dose statin + low dose GLP-1
Together, we can help you achieve your health goals and live a vibrant, fulfilling life
Population pharmacokinetic analysis of certolizumab pegol in patients with Crohns disease
Results showed that semaglutide 1.0 mg once weekly produced superior HbA1c reductions (mean decrease of 1.5% from baseline) compared to exenatide, with patients also experiencing greater weight loss (average 5.6 kg over 56 weeks)
Eplontersen for hereditary transthyretin amyloidosis with polyneuropathy